Asia Pacific Medical Technology Association

What Asia Pacific Medical Technology Association does

Asia Pacific Medical Technology Association (APACMed) is a Singapore-incorporated regional trade association founded in November 2014 and officially launched in April 2015. It serves as the unified industry voice for the medical devices and in-vitro diagnostics (IVD) sector across the Asia Pacific region, representing over 300 MedTech member organizations that span multinational manufacturers (e.g., Medtronic, Johnson & Johnson MedTech, Abbott, Stryker, Siemens Healthineers, Boston Scientific, Roche Diagnostics, B. Braun, Olympus, Terumo) and small-and-medium enterprises. The association is governed by a Board of Directors chaired by John Collings (President, Stryker Asia Pacific) and operates under CEO Harjit Gill with a small secretariat of 1-10 staff based at 2 Science Park Drive, Singapore.

APACMed's core "products" are programs and platforms rather than discrete commercial software: nine functional committees (Government Affairs & Policy, Market Access, Regulatory Affairs, Legal/Ethics & Compliance, Innovation, Health Data, Artificial Intelligence, ESG, and IVD) drive advocacy and member engagement; the APACMed Resource Hub consolidates publications, position papers and webinars; the Regulatory Intelligence Bulletin provides periodic cross-market regulatory updates; the Dashboard of Environmental Regulations for MedTech in APAC tracks ESG requirements across 11 markets; the APACMed E-Learning Hub (APACMed Academy) delivers online training; the US Tariff Tracker 2025 is a members-only supply-chain monitoring tool; and the annual MedTech Forum is the flagship event. The Regulatory Affairs Committee alone engages over 450 senior regulatory professionals, making it the association's largest committee.

Revenue is generated primarily through annual membership subscriptions across three tiers (Corporate, SME for companies under USD 50 million in sales, and Associate for institutional investors such as VC/PE firms), supplemented by event sponsorship and fees from the MedTech Forum. Go-to-market is community-led: APACMed reaches members through committees, webinars, policy forums, working groups, the website, LinkedIn, and WeChat, and handles new-member onboarding through a Business Development Director. Membership fees are not publicly disclosed and the association does not publish financial results, consistent with its not-for-profit trade body structure.

Name

Asia Pacific Medical Technology Association

Legal name

Asia Pacific Medical Technology Association Ltd.

Website

https://apacmed.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

APACMed is a Singapore-based regional trade association founded in 2014 that represents over 300 medical technology organizations across Asia Pacific. It delivers advocacy, regulatory intelligence, ESG tools, and an annual MedTech Forum, funded primarily through tiered corporate, SME, and associate membership subscriptions.

Ownership category

akta.pro rank

Product category

Medical Technology Trade Association

NAICS

Information (51)

SIC

Services-Health Services (8000)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

Keywords

• Medtech trade association
• Medical device advocacy
• Regulatory affairs network
• Industry association membership
• Healthcare policy advocacy

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: APACMed generates revenue through annual membership fees from MedTech companies, manufacturers, distributors, and service providers. Corporate Members pay higher fees while SME members (companies with sales under USD 50 million) pay substantially lower fees. Annual fees are pro-rated based on remaining months in calendar year.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

APACMed is a regional trade association that serves as the unified voice of the medical technology and in-vitro diagnostics industry across the Asia Pacific region. It delivers value to MedTech companies through tiered membership subscriptions, functional committee participation, an annual MedTech Forum, regulatory intelligence bulletins, an interactive environmental regulations dashboard, an e-learning academy, and policy advocacy engagements with regulators and governments across 11+ APAC markets.

Product overview

APACMed operates as a unified platform for the medical devices and in-vitro diagnostics industry in Asia Pacific, offering a suite of programs and resources rather than a single product. The core offerings include the APACMed Resource Hub for aggregated publications and tools, the Regulatory Intelligence Bulletin for market monitoring, the Dashboard of Environmental Regulations for ESG compliance navigation, the annual MedTech Forum for industry engagement, and APACMed E-Learning Hub for professional development. These are supported by nine functional committees addressing Government Affairs, Market Access, Legal/Ethics/Compliance, Regulatory Affairs, Innovation, Health Data, AI, ESG, and In Vitro Diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• MedTech Forum: Annual flagship conference event bringing together MedTech industry leaders across Asia Pacific
• APACMed Innovation Community (AIC)
• APACMed Resource Hub
• APACMed E-Learning Hub

Products and services

• APACMed Resource Hub

Quantifiable outcome

• Over 60% of world population expected in Asia by 2030 with significant healthcare market growth potential
• +1 more outcomes

Named customers16 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

16 partnerships are on record, tiered core, strategic and minor.

• Bain & CompanycoreStrategic or Co-development Partner · 25 November 2024APACMed partnered with Bain & Company to conduct studies on MedTech AI capabilities in the Asia Pacific region. Bain & Company provided research expertise and analytical support for the report 'Establishing the Asia-Pacific Region as a Medtech AI Capability Hub' involving more than 20 industry leaders. Bain also partnered on the 2025 ESG Dashboard covering environmental regulations across 11 APAC markets.
• K&L GatesstrategicStrategic or Co-development Partner · 11 November 2024APACMed partnered with K&L Gates as knowledge partner to produce considerations about AI and Ethics for MedTech in Asia Pacific. The legal firm provided expertise on ethical implications of AI deployment in healthcare.
• Singapore Economic Development Board (EDB)coreStrategic or Co-development Partner · 1 January 2024Singapore EDB supported the APACMed-Bain & Company study on MedTech AI capabilities in the region. EDB involvement indicates government support for positioning Asia Pacific as a Medtech AI hub.
• Bain and Co. (ESG Dashboard)coreStrategic or Co-development Partner · 1 January 2024APACMed partnered with Bain and Co. as a strategic priority focus on ESG for MedTech in APAC. Joint effort on the Dashboard of Environmental Regulations for MedTech in APAC covering 11 key markets.
• DeloittestrategicStrategic or Co-development Partner · 1 January 2020APACMed collaborated with Deloitte on a paper titled 'MedTech in APAC: Improving Health & Transforming Lives' to increase understanding of medical technologies and their role within healthcare systems and broader economies, drawing on COVID-19 experience.
• Singapore Association of Pharmaceutical Industries (SAPI)strategicStrategic or Co-development PartnerCollaboration with SAPI on healthcare policy and industry advocacy activities in Singapore. APACMed President Guillermo Frydman served as President of SAPI during his tenure as Managing Director of J&J Singapore.
• Medical Technology Association of Australia (MTAA)strategicChannel Partner/ Reseller/ DistributorPartnership with MTAA for collaboration on Australian MedTech industry initiatives, COVID-19 response campaigns including the #DontWaitMate campaign, and joint advocacy activities.
• Medicines AustraliaminorChannel Partner/ Reseller/ DistributorCollaboration with Medicines Australia on the #DontWaitMate campaign to assist in COVID-19 recovery phase in Australia.
• TSINGHUA UniversitystrategicStrategic or Co-development PartnerAPACMed conducted expert dialogue sessions with Tsinghua University on health services beyond hospitals, collaborating on research and policy discussions.
• Saw Swee Hock School of Public Health, NUSminorStrategic or Co-development PartnerCollaboration with NUS School of Public Health to facilitate discussions on border reopening and public health policy during COVID-19.
• CCCMSPIE (China Chamber of Commerce for Import & Export of Medicines & Health Products)strategicStrategic or Co-development PartnerStrategic partnership for driving bilateral and multilateral cooperation programs between China and other health-related government and non-government bodies. Facilitated government-led bilateral and multilateral cooperation mechanisms.
• MedTech InnovatorcoreGTM or Marketing PartnerPartnership with MedTech Innovator for startup mentorship and innovation ecosystem development. APACMed board member Fredrik Nyberg serves as Managing Director Asia Pacific at MedTech Innovator.
• NATHEALTH (India)strategicStrategic or Co-development PartnerCollaboration with NATHEALTH on value-based procurement in MedTech and healthcare policy in India. Joint white paper development on MedTech procurement.
• Korean Medical Devices Industry Association (KMDIA)strategicStrategic or Co-development PartnerPartnership with KMDIA for sharing expertise, best practices, and collaboration on Korean MedTech industry standards and compliance guidelines.
• Lee Kuan Yew School of Public PolicyminorStrategic or Co-development PartnerAPACMed staff member Shinae Baek previously worked at the Lee Kuan Yew School of Public Policy where she helped build research marketing efforts and managed strategic media partnerships.
• APEC (Asia-Pacific Economic Cooperation)strategicStrategic or Co-development PartnerAPACMed adheres to APEC's Modernized Kuala Lumpur Principles for ethical third-party intermediary relationships in the medical device sector.

Scale indicators8 records

Expansion highlights6 records

Market position

Strengths4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/apacmed
• LinkedInlinkedin.com/company/asia-pacific-medical-technology-association
• Xx.com/apacmed

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asia Pacific Medical Technology Association